Daewoong Pharmaceutical Strengthens Procedural Training for Medical Professionals in Asia, Latin America, and the Middle East

Global Medical Training Program to Be Held Four Times a Year

Daewoong Pharmaceutical announced on November 4 that it will increase the number of sessions for its global medical education program, the Nabota Master Class (NMC), from twice a year to four times a year.

Panel discussion in progress during the Nabota Master Class lecture session. Daewoong Pharmaceutical

The company plans to develop NMC into an educational platform that not only provides procedural training but also enhances the capabilities of medical professionals and promotes academic exchange, thereby strengthening brand trust in response to growing global market demand.

The "Deep Nabota Master Class APAC," held in Seoul for three days starting October 29, concluded successfully with the participation of over 40 medical professionals from five Asia-Pacific (APAC) countries. As the first attempt at a regionally customized educational program reflecting each country's needs and trends, the event focused on patient-tailored procedural approaches and combination treatment strategies, with numerous practical applications and clinical know-how shared among participants.

In the main sessions, Korea's leading experts-including Yoon Chunsik, Director of Yemione Dermatology; Park Jaeyoung, Director of Apgujeong Oracle Dermatology; Han Seungho, anatomy specialist and professor at Ewha Womans University; Park Youngwoon, Director of Villadskin Dermatology; Bae Kyungtae, Director of It’s Me Sejong; Ko Beomjun, Director of Doctors Dermatology Sinsa; Guk Jisoo, Director of It’s Me Ansan; and Kim Seonwook, Director of Abijou Clinic Gangseo-shared their expertise on Nabota's differentiated procedures such as NaboLift and NaboGlow, as well as combination treatments involving Viollet and Nabota. These sessions received an enthusiastic response from attendees.

Customized sessions featuring local APAC experts were also held. The "Case Sharing and Discussion" session provided an opportunity for active information and opinion exchange among global medical professionals, focusing on country- and patient-type-specific procedures and case studies from countries such as Thailand and Indonesia.

Dr. Sirinya Prabriputalung from Thailand, who participated as a speaker, said, "It was meaningful to share and discuss the latest clinical cases with global medical professionals. The systematic program, including the latest Nabota procedure training and a tour of Korea's aesthetics field, provided new insights and opportunities for growth."

Yoon Junsu, Head of Nabota Business Division at Daewoong Pharmaceutical, stated, "We will further accelerate our global market strategy by making patient-centered care the core of our approach. Beyond simple procedural training, we plan to continue developing NMC as a platform for academic exchange where global medical professionals can grow together."

This content was produced with the assistance of AI translation services.